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 Cholesterol is an integral component of neural membranes. The present 
interest in examining the changes in cholesterol and cholesterol oxidation products in 
oxidative injury in neural tissues stems mainly from the influx of new biological data 
implicating disturbances in cholesterol homeostasis in neurodegenerative disorders. 
The cytotoxicity of cholesterol oxidation products have also been demonstrated in 
numerous studies. The distribution of cholesterol and cholesterol oxidation products 
in the hippocampus after kainate injections and the toxicity of cholesterol oxidation 
products have been investigated using a model for excitotoxic injury. Intraventricular 
injections of kainate resulted in oxidative stress and increased immunostaining in the 
CA fields of the hippocampus. The increase was confirmed by increased filipin 
staining of cholesterol in adjacent sections from the same animals after kainate 
treatment. Hippocampal neuronal cultures after treatment with kainate also displayed 
increased cholesterol staining in the cell bodies and neurites. The addition of 
lovastatin, an inhibitor of cholesterol synthesis, resulted in decreased cholesterol 
staining, suggesting that the increase in cholesterol staining could be due in part to 
increase in cholesterol synthesis in kainate-treated hippocampal cultures. Gas 
chromatographic mass spectrometry analysis of cholesterol and its oxidation products 
in kainate injected rat brain indicated that there was no increase in cholesterol one day 
after kainate treatment. However, a marked increase in cholesterol and some 
cholesterol oxidation products including 7-ketocholesterol was observed three days 
after kainate treatment. Cholesterol oxidation products were toxic to neuronal slices 
as reflected by decreased staining of a neuronal marker in the affected CA fields. The 
 vii
addition of glutathione to hippocampal slices prevented the decrease in GluR1 
immunoreactivity suggesting that oxidative mechanisms are involved in cholesterol 
oxidation products-induced neuronal injury. Whilst it was realized at the outset that 
the results of this study was unlikely to provide an explanation of the precise 
mechanism(s) of neuronal damage, it was hoped that they might form the basis for a 
better understanding of the role of cholesterol oxidation products in kainate-induced 
neuronal injury. The results from this study indicate that intraventricular injections of 
kainate produced upregulation of cholesterol synthesis in brain tissue and oxidation 
products of cholesterol may be closely associated with neurodegenerative processes 
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1.1 Cholesterol in mammals   
1.1.1 Biochemistry and function 
Cholesterol (C27H46O; MW = 386.65) is required for the formation and 
function of cell membranes and a precursor of steroid hormones, bile acids and 
lipoproteins. Cholesterol synthesis was demonstrated to be mandatory for cellular 
growth and serves to supply one of the necessary building blocks for new membranes 
demanded by dividing cells during growth (Singh et al., 2003). The role of 
cholesterol in signal transduction is gaining recognition (Incardona and Eaton, 2000). 
Cellular levels of cholesterol and its compartmentalization into different organelles 
are stringently controlled, and defects in its trafficking pathway have been shown to 
give rise to metabolic storage diseases such as Niemann-Pick type C (Rukmini et al., 
2001). Additionally, Dessi et al. (1992), found that cholesterol distribution in tumoral 
lung tissues was altered in patients affected by different histologic types of lung 
cancer. This study showed that tumoral lung tissues contained two-fold more 
cholesterol than normal lung tissues. The chemical structure of cholesterol is depicted 
in Figure 1.  
 
Figure 1. The chemical structure of cholesterol. 
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  Cholesterol is transported in blood as components of lipoproteins. Dietary 
cholesterol is either transported by chylomicrons from the intestines to the liver, or 
synthesized in the liver from acetyl-coenzyme A by the de novo pathway. The 
delivery of cholesterol from the liver to the peripheral tissues is initiated by the 
esterification by cholesterol acyl transferase which is secreted into the blood stream 
as part of very low density lipoproteins. Very low density lipoproteins are 
sequentially converted to intermediate-density lipoproteins and then to low density 
lipoproteins. Peripheral tissues such as the heart, muscle and adipose tissue obtain 
most of their exogenous cholesterol from low density lipoproteins by receptor 
mediated endocytosis (Myant, 1990). Brown and Goldstein (1986) demonstrated the 
existence of the low density lipoprotein receptor, and also demonstrated the 
mechanism which showed the involvement of low density lipoprotein receptors in 
cholesterol uptake and metabolism. Cholesterol may also be removed from the liver 
by the conversion to bile acids which is used in digestion. The major bile acids are 
cholic acid and chenodeoxycholic acid are secreted as glycine or taurine conjugates 
into the gall bladder. High density lipoprotein plays the primary role in scavenging 
excess cholesterol from the tissues and returning it to the liver for metabolism or 
excretion. Circulating high density lipoprotein is widely believed to acquire its 
cholesterol by extracting it from cell surface membranes and converting it to 
cholesteryl esters through the action of lecithin cholesterol acyltransferase. 
Cholesterol has been reported to circulate back and forth between the liver and 
peripheral tissues (Brown and Goldstein, 1986; Kane, 1991; Russel and Setchell, 
1992; de Vries et al., 2003).            
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1.1.2 Intracellular cholesterol biosynthesis and uptake 
 Most mammalian cells can synthesize cholesterol. The biosynthetic pathway 
of cholesterol was initially established by Konrad Bloch in 1956. However, many 
laboratories and researchers continued to work diligently to elucidate the detailed 
pathway of cholesterol biosynthesis. It is now widely accepted that cholesterol 
biosynthesis is a complex process involving more than 30 enzymes (Tobert, 2003).   
 Cholesterol biosynthesis begins with the conversion of acetyl-coenzyme A to 
mevalonate. Mevalonate is converted to the isoprene based molecule, isopentenyl 
pyrophosphate, with the concomitant loss of carbon dioxide. Isopentenyl 
pyrophosphate is then converted to squalene. The final step is the cyclization of 
squalene to lanosterol and its transformation to cholesterol (Goldstein and Brown, 
1990; Gaylor, 2002; Herman, 2003).  In the past 10 years, proven or suspected human 
disorders involving each step of post-squalene cholesterol biosynthesis have been 
described. Smith-Lemli-Opitz syndrome was the first described disorder of post-
squalene cholesterol biosynthesis and is by far the most common. Although the 
pathogenesis of these disorders is not well understood, they underline the important 
role of cholesterol and its metabolic precursors in mammalian development (Herman, 
2003).  
 3-hydroxy-3methyl-glutaryl-coenzyme A (HMG-CoA) reductase is widely 
believed to be the rate-limiting enzyme in the cholesterol biosynthetic pathway. 
HMG-CoA reductase was a natural target in the search for drugs to reduce plasma 
cholesterol concentration, in the hope that HMG-CoA reductase inhibitors would 
reduce the risk of coronary heart disease. In early clinical trials, Lovastatin was 
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shown to be effective for lowering plasma cholesterol in healthy volunteers (Tobert et 
al., 1982). In 1987, Lovastatin became the first approved inhibitor of HMG-CoA 
reductase in the United States (Tobert, 2003). 
 Cholesterol may be externally supplied or internally synthesized. The rate of 
cholesterol biosynthesis and uptake varies in each of the major tissues of the rat under 
in vivo conditions. In rats studied under standard laboratory conditions, the brain has 
been reported to have the highest rate of cholesterol synthesis. In other organs such as 
the adrenals and the spleen, up to 95% of the requirements for cholesterol are met by 
the uptake of lipoproteins. The rate of cholesterol synthesis and uptake in the liver is 
largely dependent on physiological conditions such as the cholesterol content of the 
diet (Turley et al., 1981). 
 Michael Brown and Joseph Goldstein (1986) have demonstrated that cells 
obtain exogenous cholesterol mainly through endocytosis of low density lipoprotein 
(LDL) particles. LDL uptake involves the interaction of LDL with its receptor. The 
LDL receptor which is a cell-surface transmembrane glycoprotein binds to the B-100 
apolipoprotein. LDL which is made up of cholesterol apolipoproteins and cholesteryl 
esters, binds to the LDL receptors and is internalized in edocytotic vesicles. Several 
of these vesicles fuse to form an endosome. The endosome then fuses with the 
lysosome, placing the LDL-receptor complex in contact with the hydrolytic enzymes 
of the lysosome. The cholesteryl esters are hydrolyzed to give free cholesterol, which 
may be incorporated into the cell membranes. The internalized cholesterol exerts two 
effects: (1) High intracellular levels of cholesterol suppresses the synthesis of the 
LDL receptor; (2) Excess intracellular levels of cholesterol inhibits the biosynthesis 
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of cholesterol (Voet and Voet, 1995). Exogeneous cholesterol may also be taken up 
by cells via the nonvesicular, high-density lipoprotein (HDL) receptor/caveolar 
pathways (Schroeder et al., 2001)       
 
1.1.3 Intracellular cholesterol distribution and transport 
 It is generally accepted that the correct intracellular distribution of cholesterol 
among cellular membranes is essential for many biological functions of mammalian 
cells, including signal transduction (Maxfield and Wustner, 2002). The plasma 
membrane is estimated to contain about 60-80% of total cellular cholesterol (Liscum 
and Munn, 1999). Mammalian cells have a sensitive mechanism to control the 
amount of cholesterol in their membranes and cytoplasm. Many aspects of cholesterol 
regulation are sensitive to the concentration of cholesterol in the endoplasmic 
reticulum. This is despite the fact that the concentration of cholesterol is very low, 
comprising only 0.5-1% of total cellular cholesterol (Lange et al., 1999). For example, 
an increase in the concentration of cholesterol in the endoplasmic reticulum leads to 
am increase in the rate of degradation of 3-hyroxy-3-methylglutaryl-coenzyme A 
reductase, the enzyme which mediates the rate-limiting step of cholesterol 
biosynthesis (Blanchette-Mackie, 2000). The sterol regulatory element-binding 
protein (SREBP), sterol cleavage-actvating protein (SCAP) responds to reduction in 
the cholesterol in the endoplasmic reticulum membrane by activating proteolytic 
cleavage and translocation of a fragment of the SREBP in to the nucleus, where it 
binds to the sterol regulatory elements in the enhancers of multiple genes encoding 
enzymes of cholesterol biosynthesis (Brown and Goldstein, 1999). In cultured cells, 
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some cholesterol oxidation products, including 25-hydroxycholesterol, abolish 
cholesterol biosynthesis by blocking the Site-1 cleavage of SREBPs (Brown and 
Goldstein, 1997). These cholesterol oxidation products cannot replace the functions 
of cholesterol in cell membranes, and the cells therefore die unless they are given a 
usable exogenous source of cholesterol (Metherall et al., 1991).    
Newly synthesized cholesterol in the endoplasmic reticulum is transported to 
the plasma membrane by an ATP-dependent mechanism (DeGrella and Simoni, 1982; 
Liscum and Munn, 1999; Hao et al., 2002). Pharmcological inhibition studies using 
brefeldin A showed that de novo synthesized cholesterol is mainly transported from 
the endoplasmic reticulum directly to the plasma membrane. These results suggest 
that the vesicle-mediated protein pathway in not a major pathway of cholesterol 
transport from the endoplasmic reticulum to the plasma membrane (Urbani and 
Simoni, 1990; Heino et al., 2000).  Caveolae and caveolin have been proposed to play 
an important role in intracellular transport. It was considered likely that caveolin 
forms a complex with chaperone proteins that deliver cholesterol from the 
endoplasmic reticulum to the plasma membrane and that palmitoylation of caveolin-1 
may be required for cholesterol binding and transport complex formation 
(Uittenbogaard and Smart, 2000)  
Although the vesicular pathway is not a major pathway of cholesterol export 
from the endoplasmic reticulum, a recent study found that the passage of some 
cholesterol exported from the endoplasmic reticulum through the Golgi apparatus 
might be important for raft-dependent sorting in the trans-Golgi network of polarized 
epithelia (Simons and Ikonene, 1997). Moreover, treatment of cells with bacterial 
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sphingomyelinase, which releases cholesterol from the plasma membrane, vesicle-
mediated transport of cholesterol was found to be important in the distal pathway of 
lipoprotein-induced cholesterol esterification (Skiba et al., 1996). These results 
suggest that the possible mechanisms of intracellular cholesterol transport include 
both vesicular and nonvesicular mechanisms which might operate separately or in 
parallel within the cell. 
Plasma cholesterol esters in the LDL are delivered to late endosomes and 
lysosomes for hydrolysis. The mechanisms by which cholesterol is exported from the 
lysosomes are still not fully understood. Approximately 70% of the cholesterol 
exported form the lysosome is delivered to the plasma membrane (Brassamle and 
Attie 1990; Johnson et al., 1990). It was considered likely that the other 30% of the 
cholesterol of the LDL-derived cholesterol is delivered to the endoplasmic reticulum 
by a pathway that is independent of the plasma membrane (Neufield et al., 1996; 
Liscum and Munn, 1999). 
 Niemann-Pick C disease is an autosomal recessive inheritance disease 
(Kobayashi et al., 1999; Blanchette-Mackie, 2000). The disorder is characterized by 
excessive build up of cholesterol inside lysosomes in the central nervous system. 
Cells from Niemann-Pick C patients have been shown to be defective in releasing 
cholesterol from lysosomes (Carstea et al., 1997; Loftus et al., 1997). The Nieman-
Pick C1 (NPC1) protein is a multiple membrane spanning protein that may be 
required for vesicular shuttling of both membrane lipids and fluid phase constituents 
from the late endosome to various destinations (Neufield et al., 1999; Liscum, 2000). 
In a recent study using a novel cholesterol stain, it was shown in NPC1 mouse models 
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at postnatal day 9 that although only mild signs of neurodegeneration were detectable, 
significant neuronal cholesterol accumulation had already occurred in the brain. In the 
same study, it was also shown in the NPC mouse brain in vivo that neuronal 
cholesterol accumulation precedes neurodegeneration and neuronal cell loss (Reid et 
al., 2004). 
 Excess intracellular free cholesterol is cytotoxic (Kellner-Weibel et al., 2003). 
Mechanisms of cellular toxicity associated with free cholesterol accumulation include 
changes in the physiological free cholesterol/phospholipid ratio in cellular 
membranes (Simons and Ikonen, 2000), cholesterol crystallization (Lupu et al., 1987; 
Kneller-Weibel et al., 1999), cholesterol oxidation products formation (Brown and 
Jessup, 1999; Bjorkhem, 2002) and the triggering of apoptotic pathways (Kneller-
Webel et al., 1998; Yao and Tabas, 2000, 2001). To maintain cellular cholesterol 
homeostasis, cells are protected from the accumulation of free cholesterol by acyl 
coenzyme A:cholesterol acyltransferase (ACAT) mediated esterification or by 
cholesterol efflux. Efflux pathways may be inhibited by conversion of cholesterol to 
cholesterol oxidation products. Some cholesterol oxidation products have been shown 
to promote free cholesterol efflux while others such as 25-hydroxycholesterol and 7-
ketocholesterol exacerbate cholesterol accumulation by inhibiting free cholesterol 
efflux and/or ACAT mediated cholesterol esterification (Brown and Jessup, 1999). 
Excess cholesterol is stored as cholesteryl esters through an esterification process 
regulated by ACAT. The cholesterol esterifying enzyme is found in many tissue types 
and localized in certain parts of the endoplasmic reticulum (Heinonen, 2002). 
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However, loading of choelsteryl esters in the cytoplasmic droplets of macrophage 
play an important role in the formation of atherosclerotic lesions (Tabas, 2002).  
One of the most widely used tools to visualize cholesterol accumulation in 
cells is filipin staining. Filipin binds to cholesterol with high affinity and selectivity, 
making it suitable for use to detect cholesterol in various membrane organelles in 
cells (Schroeder et al., 1971). Although filipin fluorescence is not necessarily linearly 
related to cholesterol concentration, filipin has been widely used for the qualitative 
analysis of cholesterol distribution (Steer et al., 1984). Recently, a novel method for 
detecting cholesterol-rich domains utilizing the cholesterol binding agent BC-theta 
was developed by a group of researchers and the complexes formed may be 
visualized under fluorescence microscopy more efficiently when compared to filipin 
(Reid et al., 2004). 
 
1.1.4  Cholesterol and human diseases 
 As early as 1913, Anitschkow and Chalatow showed that there was link 
between the levels of plasma cholesterol and atherosclerosis. Since then numerous 
studies have demonstrated that high levels of plasma cholesterol are correlated with 
coronary heart disease (Steinberg and Gotto, 1999). The Framingham study which 
was initiated in 1948 (Kannel, 2000, 2002), is perhaps the most striking piece of 
evidence which supports the link between high plasma cholesterol and coronary heart 
disease. This study investigated the evolution of cardiovascular disease over five 
decades in a general population sample of men and women. This study also provided 
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insights in the prevalence, incidence, and predisposing factors for coronary heart 
disease, stroke, periphery heart disease and heart failure.  
Alzheimer’s disease (AD) was first described by Alois Alzheimer in 1907. 
The disease is characterized by the formation of amyloid plaques and neurofibrillary 
tangles. It is now known that cholesterol accumulates in the senile plaques of 
Alzheimer’s disease patients (Mori et al., 2001). Cholesterol has been implicated in 
the pathogenesis of amyloid plaques in Alzheimer’s disease (Wolozin, 2002; 
Michikawa, 2003; Wolozin, 2004). Recent epidemiological studies have 
demonstrated a correlation between elevated serum cholesterol and the development 
of Alzheimer’s disease (Notkola et al., 1998; Launer et al., 2001). The major 
component of amyloid plaques is the amyloid-β peptide that is derived from the 
amyloid precursor protein. Accumulation of amyloid-β peptide is associated with 
Alzheimer’s disease. Several studies have shown that cholesterol levels modulate the 
processing of the amyloid precursor protein, which in turn affects the synthesis and 
accumulation of amyloid-β peptide (Bodovitz and Klein , 1996; Simons et al., 1998; 
Yanagisawa, 2003). Interestingly, studies have demonstrated that amyloid-β peptide 
affects the cellular cholesterol level. Amyloid-β peptide induced alteration in 
cholesterol metabolism can have pronounced effect on the cell structure and function 
(Burns and Duff, 2002; Wood and Igbavboa, 2003). Neurons are sensitive to 
alterations in lipid transport (Futerman and Banker, 1996). The amyloid-β peptide 
induced increase in membrane cholesterol could decrease membrane fluidity and 
contribute to membrane instability as well as the loss of cholinergic neurons 
(Pentchev et al., 1994). Studies have shown that the apolipoprotein E4 allele is linked 
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to a higher risk of Alzheimer’s disease, conversely individuals with apolipoprotein E2 
allele may be at a lower risk (Burns and Duff, 2002; Raffai and Weisgraber, 2003).  
ApoE is a major lipid transporter in the brain leading to suggestions that ApoE is 
critical in the transport of cholesterol in the brain for normal neuronal maintenance 
and repair after injury. It has been hypothesized that ApoE is involved in the normal 
maintenance and remodeling of neurons as well as neuronal repair (Mauch et al., 
2001). 
 
1.2 Cholesterol oxidation products in mammals 
1.2.1 Biochemistry 
Cholesterol is susceptible to oxidation to form cholesterol oxidation products. 
Cholesterol oxidation products are defined as oxygenated derivatives of cholesterol 
that may be formed directly by autoxidation or by the action of specific 
monooxygenase or may be secondary to enzymatic or nonenzymatic lipid 
peroxidation (Bjorkhem and Diczfalusy, 2002). To understand the potential 
physiological importance of cholesterol oxidation products in humans, many 
investigations have focused on the determination of the levels of cholesterol oxidation 
products in blood, various tissues and food products. Up to 80 cholesterol oxidation 
products have been separated and identified using thin-layer chromatography, high-
performance liquid chromatography or gas chromatography-mass spectrometry (Tai 
et al., 1999).  Cholesterol oxidation products have been shown to possess a diverse 
range of biological activities (Guardiola et al., 1996; Schroepfer, 2000; Bjorkhem and 
Diczfalusy, 2002). It has been proposed that the synthesis of 24- or 27-
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hydroxycholesterol in macrophages, kidney and brain facilitates the removal of 
extrahepatic cholesterol from these peripheral tissues (Meaney et al., 2002). There is 
also considerable evidence that cholesterol oxidation products may contribute to the 
development of atherosclerosis (Brown and Jessup, 1999). Many cholesterol 
oxidation products have also been found to be inhibitors of cholesterol biosynthesis 
(Kandutsch and Chen, 1978).  
Various cholesterol oxidation products have been detected in the blood and 
tissues of animals and man as well as in food products. The sources of cholesterol 
oxidation products in human plasma and tissues remain controversial. Researchers 
have proposed three sources of cholesterol oxidation products in human plasma and 
tissues: (1) through dietary sources; (2) formed by non-enzymatic oxidation in vivo; 
and (3) formed by enzymatic oxidation in vivo (Brown and Jessup, 1999). In view of 
the multiple actions of cholesterol oxidation products, their occurrence and 
concentrations in natural and processed food have drawn much attention because of 
their potential health implications. Foods rich in cholesterol content such as diary 
products, eggs and meat products, are prone to undergo autoxidation or enzymatic 
oxidation, resulting in the formation of cholesterol oxidation products (Sander et al., 
1989; Fontana et al., 1993). It has been estimated that approximately 1% of the 
cholesterol consumed in a mixed western diet is oxidized (van de Bovenkamp et al., 
1988).  Jacobson and his colleagues reported the presence of high levels of 
cholesterol oxidation products in Indian ghee which is used extensively in traditional 
Indian cooking. They suggested that the ingestion of these compounds in ghee might 
be responsible for the high incidence of atherosclerosis in Indian populations living in 
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London as compared with non-Indians in the same city (Jacobson, 1987). Prasad and 
Subramanian (1992) subsequently reported the presence of cholesterol epoxides in 
home-made ghee.  Several studies have demonstrated that dietary cholesterol 
oxidation products can be absorbed (Sarma et al., 1976; Emmanual et al., 1991; Krut 
et al., 1997; Vine et al., 1997). The reported values of absorption from these studies 
varied greatly. Results from these studies cannot be compared directly because in 
each of the experiments the dose, model and vehicle used to administer the 
cholesterol oxidation products differed. Of 13 studies on the effect of dietary 
cholesterol oxidation products, 6 indicated a proatherogenic effect, 4 indicated an 
antiatherogenic effect and 3 showed no clear-cut activity (Brown and Jessup, 1998). 
Consequently, the role of normal dietary intake of cholesterol oxidation products on 
the development of atherosclerosis remains uncertain. 
 There is a growing body of evidence which supports the formation of some 
cholesterol oxidation products in vivo (Hodis et al., 1991; Johnson et al, 1994; Breuer 
and Bjorkhem, 1995). However, it is difficult to distinguish between an enzymatic 
and non-enzymatic formation of cholesterol oxidation products in vivo. It has been 
suggested that the 7β-hydroxycholesterol and 7-ketocholesterol are principally non-
enzymatic in origin while cholesterol 5α, 6α-epoxide and cholesterol 5β, 6β-epoxide 
may be exclusively of dietary origin (Kudo et al., 1989; Breuer and Bjorkhem, 1995; 
Brown and Jessup 1999). The cytochrome P-450 responsible for the formation of 
24S-hydroxycholesterol, 24S-hydroxylase was found to be almost exclusively located 
in the brains of humans (Bjorkhem et al., 1998; Lund et al., 1999). Consequently, a 
group of researchers suggested that the levels of 24S-hydroxycholesterol in the 
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circulation reflect the balance between cerebral production and hepatic degradation 
and may provide some insights concerning cholesterol homeostasis in the brain in 
connection with neurodegenerative diseases (Bretillion et al., 2000)  More recently, it 
has been suggested that the levels of cholesterol oxidation products and alpha-
tocopherol in plasma and tissue samples may be used as indices of oxidant stress 
status (Iuliano et al., 2003).  Some of the cholesterol oxidation products are depicted 








cholesterol 5β, 6β-epoxide  
Figure 2. The chemical structure of some cholesterol oxidation products. 
 
 
1.2.2  Biological effects of cholesterol oxidation products 
 
 A number of in vitro studies have demonstrated the cytotoxic effects of 
cholesterol oxidation products on cultured endothelial cells (Sevanian et al., 1991; 
Zhou et al, 2000), smooth muscle cells (Hughes et al., 1994; Ares et al., 2000) and 
macrophages (Clare et al., 1995). The changes which have been taken as indicative of 
cytotoxicity include, changes in cell growth, viability, plating efficiency of cells, 
morphology, metabolic activity in viable cells using MTT assay, influx of calcium, 
protein synthesis and DNA synthesis. Zhou et al. (2000) reported on the cytotoxicity 
of cholesterol oxidation products in cultured endothelial cells. Their results indicated 
that there was enhanced influx of calcium into endothelial cells cultured in the plasma 
from patients with excess concentration of cholesterol oxidation products as 
compared to endothelial cells in the plasma from controls.  
 The exact mechanisms of cholesterol oxidation products toxicity are not 
known, but have been suggested to include inhibition of cholesterol synthesis through 
lowering of hydroxyglutaryl coenzyme A reductase activity (Breslow et al., 1975; 
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Kandutsch and Chen, 1978), inhibition of DNA synthesis (Guardiola et al., 1996), 
alterations in permeability to ions (Peng et al., 1985, Guardiola et al., 1996) and 
replacement of cholesterol in membranes by cholesterol oxidation products with 
associated perturbations to their vital properties (Rooney et al., 1986; Theunissen et 
al., 1986; Lupu et al., 1987). More recently, cholesterol oxidation products have been 
shown to induce degradation of the pro-survival protein, Akt(PKB) in a murine-
macrophage cell line. This, in turn, leads to the activation of the BH3 only proteins 
Bim and Bad and down regulation of the anti-apoptotic multi-Bcl homology domain 
protein Bcl-XL. These responses would then be expected to activate the pro-apoptotic 
multi-Bcl homology domains Bax and Bak leading to a release of cytochrome c 
(Rusinol et al., 2004).  
 
1.3  Analysis of cholesterol and cholesterol oxidation products 
Methods employed for the analysis of cholesterol oxidation products have 
been published in many papers during the past 20 years. Prior to the quantitative step 
by thin-layer chromatography, high performance liquid chromatography or gas 
chromatography – mass spectrometry, cholesterol and cholesterol oxidation products 
must be separated from other constituents such as proteins and impurities. The 
analysis of cholesterol and cholesterol oxidation products involves 2 main steps, the 
so called “clean-up” step which is often referred to as the extraction procedure 
followed by the quantitative step.  
As early as 1957, Folch and his colleagues described an efficient extraction 
procedure. Since then, many other researchers have described methods for the 
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extraction of cholesterol oxidation products in food products or biological fluids. The 
methods mainly differed by the use of different solvent mixtures: 
chloroform/methanol for Folch’s method (Folch et al., 1957), 
dichloromethane/methanol for Maxwell’s method (Maxwell et al., 1986) and 
hexane/2-propanol for Eder’s method (Eder et al., 1993). Some extraction 
methodologies in published data included a “saponification” step which may lead to 
formation of artifacts or disruption of cholesterol oxidation products (Park et al., 
1996). 
 Many analytical methodologies for the identification and quantification of 
cholesterol oxidation products in food and biological fluids have been used. They 
include thin-layer chromatography (Teng et al., 1973; Rennert et al., 1990), high 
performance liquid chromatography with mass selective detector or evaporative light 
scattering detector (Sevanian et al., 1994; Lakritz & Jones., 1997; Razzazi-Faceli et 
al., 2000), gas chromatography and the flame ionization detector (Park et al., 1986) or 
gas chromatography – mass spectrometry (Abo et al., 2000; Tsuzuki et al., 2000; 
Moriel et al., 2002). Gas chromatography – mass spectrometry quantification 
working in the selected ion mode is generally accepted as the most selective and 
sensitive (Rose-Sallin et al., 1995).  The mass spectrometer consists of 3 main 
components. The ion source receives the sample and produces ions. The mass filter, 
or quadrupole, sorts these ions based upon their mass-to-charge ratio (m/z). The mass 
selective detector produces a signal proportional to the number of ions striking it. 
This detector may be made very specific by appropriate selection of masses. 
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Sevanian et al. (1994) compared methodologies of two methods for the 
analysis of plasma cholesterol oxidation products; one involved the application of 
high performance liquid chromatography-mass spectrometry, while the other 
involved the application of gas chromatography-mass spectrometry. It was reported 
that analysis of cholesterol oxidation products from plasma samples revealed distinct 
advantages for each method according to the specific cholesterol oxidation product in 
question. In the same study, it was shown that while high performance liquid 
chromatography – mass spectrometry analysis of cholesterol oxidation products 
provided less resolution and lower sensitivity as compared to gas chromatography – 
mass spectrometry, there was a distinct advantage for direct measurements of 
cholesterol-7-hydroxperoxides and 7-ketocholesterol.  One interesting aspect of this 
study was that cholesterol-7-hydroxyperoxides are either unstable and decompose in 
plasma, are metabolized to other cholesterol oxidation products or breakdown during 
their isolation. In addition, cholesterol oxidation products require a derivatization step 
for gas chromatographic separation, which extends the analysis time. However, 
derivatization to trimethylsilyl esters increase their thermal stability and volatility, 
making them amenable to gas chromatography-mass spectrometry analysis. 
Park and Addis (1985) presented detailed capillary gas chromatography data 
using a DB-1 column for the trimethylsilylated derivatives of several cholesterol 
oxidation products including 7-ketocholesterol, 7β-hydroxycholesterol, 25-
hydroxycholesterol and cholesterol 5α, 6α-epoxide. They found each of the 
cholesterol oxidation products to have excellent response linearity as 
trimethylsilylated sterol enabling reliable quantification. The identity of each 
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derivatized sterol was subsequently confirmed by mass spectrometry (Park and 
Addis, 1985).   
One of the aims of this study was to develop a method which was simple and 
fast yet accurate and reliable for the routine analysis of cholesterol oxidation products 
in rat brain tissues. However, the analysis of cholesterol oxidation products in rat 
brain tissues has been difficult because it is present only in low concentrations. Hence, 
the choice of the extraction procedure and instrument posed a challenge which needed 
to be addressed. 
 
1.4      Aims and objectives of the study 
Cholesterol is a lipid found naturally in membranes of eukaryotic cells. 
Numerous studies have shown that cholesterol oxidation products may influence vital 
cellular processes such as de novo sterol biosynthesis (Addis, 1990), cell growth 
(Higley and Taylor, 1984), cell membrane function (Peng et al., 1991) and cell 
proliferation (Morin et al., 1991).  However, little information has been obtained 
concerning the effects of changes in sterol, in particular cholesterol and cholesterol 
oxidation products in oxidative injury in neural tissues. The relationship between 
cholesterol and cholesterol oxidation products and neurodegeneration remains unclear. 
 The present interest in the analysis of cholesterol and cholesterol oxidation 
products in kainate-injected rat hippocampus stems mainly from the growing body of 
evidence implicating disturbances in cholesterol homeostasis in neurodegenerative 
disorders. The results from a study by Eckert et al. (2000) is perhaps one of the more 
striking piece of evidence which supports the existence of one or more mechanisms 
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linking disturbances in cholesterol metabolism to the pathophysiology of 
neurodegenerative disorders. This same study reported that abnormalities in 
cholesterol metabolism play a role in the pathophysiology of Alzheimer’s disease 
(AD). 
Cholesterol and cholesterol oxidation products have been implicated in 
atherosclerosis and heart diseases (Imai et al., 1984; Peng et al., 1991), but remains 
largely understudied in relation to neuronal function. This led to a number of studies 
which endeavored to study the role of cholesterol in neuronal function and 
neurodegeneration. Results from studies have suggested that changes in the 
cholesterol content of intracellular membranes alter the trafficking of membrane 
proteins and cholesterol have been shown  to modulate the processing of amyloid 
precursor protein as well as the cellular generation of β-amyloid peptide (Hartmann et 
al., 1994; Bodovitz et al., 1996; Frears et al., 1999). 
Cholesterol is essential for neuronal viability and for neuronal and glial cell 
function in the brain (Dietschy and Turley, 2001). It is generally accepted that 
cholesterol affects the physiochemical properties of neural membranes and also 
regulates the activities of membrane bound enzymes, receptors and ion channels 
(Papahadjopoulos et al., 1973; Heron et al., 1980). One study has suggested that 
cholesterol plays a role in the modulation of dendritic and therefore synaptic 
remodeling and tau phosphorylation which are central processes of relevance to the 
biology of neurons in AD brains (Fan et al., 2001).  
Cholesterol homeostasis is carefully maintained in the brain through a series 
of interdependent processes, including synthesis, storage, degradation and transport.  
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It was suggested that changes in cholesterol homeostasis may cause alterations 
in cholesterol recycling and cholesterol transporter, apolipoprotein E expression 
within the nervous system, which, in turn, may affect neuron and myelin integrity 
(Dietschy and Turley, 2001). Clinical and epidemiological data have indicated that 
patients with elevated cholesterol have increased susceptibility to AD (Roher et al., 
1999). The incidence of AD is higher in western countries suggesting a possible link 
with the consumption of high-fat and high caloric diets (Kalmijin et al., 1997). 
Several studies have shown that cholesterol-lowering drugs such as statins may 
reduce the risk of Alzheimer’s disease (Jick et al., 2000; Rockwood et al., 2002). 
These findings are consistent with two independent studies which have shown that 
guinea pigs receiving high does of simvastatin for several weeks showed reduced 
levels of β-amyloid in the brain (Fassbender et al., 2001; Refolo et al., 2001). As 
early as 1994, Sparks and his colleagues showed that in animals fed with cholesterol-
enriched diets for 4, 6 and 8 weeks, there was accumulation of intracellular 
immunolabeled  β-amyloid. This study also provided experimental evidence that 
suggests that cholesterol plays a role in the alteration of β-amyloid precursor protein 
metabolism leading to β-amyloid accumulation. The exact mechanism by which 
cholesterol alters β-amyloid production is not well understood. Cholesterol exerts 
numerous effects in the amyloid precursor protein (APP) secretase function. Increases 
in intracellular cholesterol concentrations lead to inhibition of α-secretase activity but 
stimulate β- and γ-secretase activities (Poirier, 2003). More studies are required to 
understand the role of cholesterol in the pathophysiology of neurodegenerative 
disorders.  
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Cholesterol oxidation products have been shown in various experimental 
models to possess biological effects such as apoptosis (O’Callaghan et al., 1999; 
Rusinol et al., 2004), cytotoxicity (Zhou et al., 2000; Miguet-Alfonsi et al., 2002), 
mutagenicity (Sevanian and Peterson, 1986), angiotoxicity (Peng et al., 1991; Dorset, 
1992), carcinogenicity (Morin et al., 1991) and cell membrane damaging properties 
(Higley and Taylor, 1984; Smith and Johnson, 1989; Peng et al., 1991; Vatassery et 
al., 1997).   
Another interesting aspect of cholesterol oxidation is the growing concern 
about the potential cytotoxic, mutagenic and possibly carcinogenic effects of some 
cholesterol oxidation products. These oxidation products are found in many 
commonly-consumed foods that are formed during their manufacture and/or 
processing. Valenzuela et al. (2003) found that some natural antioxidants, such as 
alpha and gamma-tocopherol, rosemary, oleoresin extract and the flavonoid quercetin, 
show strong inhibitory action against cholesterol oxidation. 
As early as 1978, Kandutsch and his colleagues reported that cholesterol 
synthesis in isolated cultured cells was suppressed by cholesterol. In the same study 
he found that the inhibitory potency of some of the cholesterol oxidation products 
such as 25-hydroxycholesterol was much higher than that of cholesterol itself. Their 
results suggested that cholesterol oxidation products may have a role as regulators of 
cholesterol homoeostasis. Since then, several other studies have been conducted to 
study the regulatory importance of cholesterol oxidation products in the regulation of 
cholesterol homeostasis (Metherall et al., 1989; Saucier et al., 1989; Zhang et al., 
2001). More recently, experiments involving feeding rats with atherogenic diet or the 
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administration of mevalonate concluded that 25-hydroxycholesterol may be of 
importance in the regulation of cholesterol homeostasis (Zhang et al., 2001). 
 It is becoming increasingly evident that cholesterol oxidation products 
modify neural membrane function. They not only alter calcium influx but also inhibit 
Na+, Ca2+-exchanger and Ca2+, Mg2+ ATPase activity (Kutryk et al., 1991). 
Cholesterol oxidation products are potent and highly stereospecific modulators of 
calcium channels and are known to increase fluidity of brain synaptic membranes 
(Neyses et al., 1985; Wood et al., 1995). The cytochrome P-450 responsible for the 
formation of 24-hydroxycholesterol, cytochrome P-450 is almost located exclusively 
in the brain of humans (Bjorkhem et al., 1998; Lund et al., 1999). There is a 
continuous flux of 24-hydroxycholesterol across the blood brain barrier into the 
circulation, and evidence has been provided that this flux is of importance for the 
homoeostasis of brain cholesterol (Lutjohann et al., 1996; Bjorkhem et al., 1998).  
The concentration of 24-hydroxycholesterol is 30 to 1500-fold higher in brain tissue 
than in any other organ and it was reported that 24-hydroxycholesterol plasma 
concentration is a peripheral indicator of neurodegeneration occurring in Alzheimer’s 
disease and possibly also in other neurodegenerative disorders (Lutjohann et al., 1996, 
2000). It has recently been suggested that the serum concentration of 24-
hydroxycholesterol which reflects that the brain cholesterol turnover may be a 
possible marker for neurodegeneration and demyelination in multiple sclerosis 
(Teunissen et al., 2003). Another interesting aspect of the biological effects of 
cholesterol oxidation products is that 7-ketocholesterol and 25-hydroxycholesterol 
cause apoptosis and significantly decrease viability in microglial cell cultures (Chang 
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et al., 1998). In non-neural cells, 7-ketocholesterol is known to induce the conversion 
of pro-interleukin-1β to interleukin-1β, a cytokine that stimulates cPLA2 activity 
(Lizard et al., 1997, Farooqui et al., 1999). 
Large amounts of free radicals and lipid peroxidation products formed in the 
hippocampus after kainate-induced excitotoxic brain injury (Farroqui et al., 2001). 
After kainate injury of hippocampus, there is a decrease in immunoreactivity of the 
antioxidant glutathione (Ong et al., 2000a), accompanied by an increase in the lipid 
peroxidation product, 4-hydroxynonenal (Ong et al., 2000b). It might be expected 
that high levels of free radicals and lipid peroxidation products would lead to 
increased formation of cholesterol oxidation products in the degenerating 
hippocampus, and that these, in turn would lead to neuronal injury. However, a 
detailed analysis of cholesterol oxidation products have not been carried out after 
kainate induced excitotoxic injury. This study was designed to establish whether high 
levels of free radicals and lipid peroxidation products would lead to increased 
formation of cholesterol oxidation products in the degenerating hippocampus. Thus 
far, quantification of cholesterol oxidation products has not been carried out after 
kainate induced excitotoxic injury. 
 The overall aims of this study were thus to investigate the distribution of 
cholesterol and cholesterol oxidation products in the hippocampus after kainate 
injections and to study the toxicity of cholesterol oxidation products in hippocampal 
slice cultures. It is hoped that these studies together with the quantification of 
cholesterol and COPs in the degenerating rat brain might form the basis for a better 
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2. Materials and Methods 
2.1 Ethics approval 
All procedures involving animals had been approved by the Medical Faculty 
Animal Care and Use Committee. 
 
2.2 Experimental procedure and design 
2.2.1 Animals and Kainate injections 
Wistar rats weighing approximately 250g were anaesthetized with an 
intraperitoneal injection of 1.2ml of 7% chloral hydrate, and the cranial vault exposed. 
Kainate (1.5µl of a 1mg/ml solution) was injected into the right lateral ventricle 
(coordinates: 1.0mm caudal to bregma, 1.5mm lateral to the midline, 4.5mm from the 
surface of the cortex) using a microliter syringe. The needle was withdrawn 10 
minutes later, and the scalp sutured. Experimental rats were injected with 1.5µl of 
saline instead of kainate. The brains were removed, and a block consisting of the 
posterior half of the forebrain, and including the hippocampi was dissected out. 
 
2.2.2 Immunocytochemistry 
The blocks were sectioned coronally at 100µm using a vibrating microtome. 
The sections were washed for 3 hours in phosphate buffered saline (PBS) to remove 
any traces of fixative, and immersed for 1 hr in a solution of 2% defatted dry 
(skimmed) milk in PBS (PBS-milk) to block non-specific binding of antibodies. They 
were then incubated overnight with affinity-purified rabbit polyclonal antibody to the 
glutamate receptor subunit GluR1 (Chemicon, diluted 1µg/500µl), and a mouse 
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monoclonal antibody to cholesterol (MAb 2C5-6). The antibody to cholesterol has 
been characterized previously, and to be specific to cholesterol (Swartz et al., 1988). 
The sections were washed in three changes of PBS, and incubated for 1 hr at room 
temperature in a 1:200 dilution of biotinylated goat anti-rabbit IgG, or horse anti-
mouse IgG (Vector). Sections were then reacted for 1hr at room temperature with an 
avidin-biotinylated horseradish peroxidase complex. The reaction was visualized by 
treatment for 5min in 0.05% 3,3,diaminobenzidine tetrahydrochloride solution in Tris 
(pH 7.6) buffer containing 0.05% hydrogen peroxide. The colour reaction  was 
stopped with several washes of Tris buffer, followed by PBS. The sections were 
mounted on glass slides and lightly counterstained with methyl green before 
coverslipping. Control sections were incubated with PBS instead of primary antibody. 
 
2.2.3 Electron microscopy 
Electron microscopy was carried out by subdissecting the cholesterol 
immunostained sections from the control or kainate injected rats into smaller 
rectangular portions that included the lesioned CA fields. These were dehydrated in 
an ascending series of ethanol and acetone, and embedded in Araldite. Thin sections 
were obtained from the first 5µm of the sections, mounted on copper grids coated 
with Formvar, and stained with lead citrate. They were viewed using a Jeol 1200EX 





2.2.4 Hippocampal slice cultures and neuronal cultures 
Organotypic hippocampal slice cultures were prepared as previously described 
(Stoppini et al., 1991), with minor modifications (Lu et al., 2001). In brief, 10-day old 
Wistar rat pups were anesthetized with intraperitoneal injections of 7% chloral 
hydrate, decapitated, and the brains removed. The hippocampi were dissected out, 
and sectioned transversely at 400 µm thickness using a tissue chopper. The slices 
were transferred to 30 mm Millicell CM culture plate inserts with 0.4 µm 
polytetrafluoroethylene membranes (Millipore, Bedford, Mass), and placed in 6 well 
culture plates containing culture medium (50% minimum essential medium [Gibco], 
25% fetal calf serum [Sigma], 25% Hanks balanced salt solution [Gibco], 
supplemented with D-glucose [6.5 mg/ml, Sigma], glutamine [2 mM, Gibco], 
penicillin G [1 unit/ml, Gibco] and streptomycin sulfate [1 µg / ml, Gibco], pH 7.15). 
The slices were maintained at 37°C, 100% humidity and 95% air and 5% CO2. The 
medium was changed to a fresh medium after 3 and 7 days in culture.  
 Two to 4-day-old Wistar rat pups were deeply anesthetized by intraperitoneal 
injections of chloral hydrate, decapitated, and the brains removed. The hippocampi 
were dissected out and incubated with 2 ml of 0.25% trypsin at 37°C for 10 minutes. 
The tissues were then washed 3 times with Dulbecco’s modified Eagles medium 
(DMEM). A cell suspension was then prepared by triturating the tissue with a flame 
polished Pasteur pipette. The cells were plated on poly D-lysine coated culture dishes 
at a final density of approximately 500 000 cells per cm2, and maintained in an 
incubator at 37°C, 100% humidity and 95% air and 5% CO2. The culture medium 
was changed to a fresh medium after 3 days in culture, and 2 ×10-5 M cytosine 
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arabinoside (Sigma) added to eliminate glial cells. The culture medium was changed 
to a fresh medium after a further 4 days in culture. 
 
2.2.5 Gas chromatography-mass spectrometry 
Cholesterol and cholesterol oxidation products in the rat hippocampus after 
kainate injections were identified and quantified using a Hewlett-Packard 6890 gas 
chromatograph coupled to a 5973 mass selective detector. The GC column was HP-5 
(25mm x 0.2mm i.d. cross-linked 5%-diphenyl 95%-dimethylsiloxane). 
 
2.3 Specific Methods 
2.3.1 Immunocytochemical labeling of cholesterol in hippocampal sections 
after kainate injection 
Twenty-four rats were used for this portion of the study, of which 16 were 
injected with kainate and 8 were saline-injected controls. The kainate-injected and 
control rats were sacrificed at 1 day, 3 days, 1 week and 2 weeks after injection (4 
kainate-injected rats and 2 controls at each time point). The rats were deeply 
anaesthetized by intraperitoneal injection of 1.5ml of 7% chloral hydrate and perfused 
through the left cardiac ventricle with a solution of 4% paraformaldehyde in 0.1M 
phosphate buffer (pH 7.4). The brains were removed, and a block consisting of the 
posterior two thirds of the forebrain, including the hippocampi, dissected out. The 
blocks were sectioned coronally at 100µm using a vibrating microtome. The sections 
were divided into 3 sets; the first two were used for immunocytochemistry, while the 
third was used for histochemical staining for cholesterol. Sections intended for 
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immunocytochemistry were prepared using the method described above. The 
remaining sections were further processed for electron microscopy. 
 
2.3.2 Filipin histochemical labeling of cholesterol in hippocampal sections, 
slices and neuronal cultures after kainate treatment. 
2.3.2a Hippocampal sections                                                                                                                        
The third set of sections from the kainate or saline injected rats above was 
stained by a modification of the filipin method for cholesterol as follows: a stock 
solution of filipin was prepared by dissolving 3.3 mg of filipin III (Sigma) in 100µl of 
dimethyl sulfoxide (DMSO). A working solution was prepared by diluting 3µl of the 
stock solution in one ml of PBS, and sections were incubated in this solution for 4 
hours in the dark. The sections were washed in PBS, coverslipped using a water-
soluble mountant, and viewed using a fluorescence microscope (Zeiss Axiophot with 
a 365 nm UV filter) 
 
2.3.2b Hippocampal slice cultures 
Hippocampal slices were treated with 100µM kainate after 7 days in culture. 
They were fixed in a solution of 4% PF in 0.1 M phosphate (pH 7.4) buffer the 
following day, and stained with filipin using the method described above. 
 
2.3.2c  Hippocampal neuronal cultures 
Hippocampal neurons were treated with kainate (1:10 dilution of a one mg/ml 
stock solution of kainate in DMEM), or lovastatin (1:10 dilution of a 1mg/ml stock 
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solution of lovastatin in DMEM) followed 16 hours later by incubation with kainate 
for 3 hours. They were fixed in 4% PF and 0.1 M phosphate (pH 7.4), and stained for 
filipin. An image of the cultured neurons was then captured using bright-field 
illumination, followed by a second image using fluorescence illumination to 
demonstrate filipin-labeled neurons. The number of filipin-positive neurons was 
expressed as a percentage of the total number of neurons identified at brightfield, and 
possible statistical differences in this ratio between kainate-treated, and lovastatin 
plus kainate-treated neurons analyzed using Student’s t-test. 
 
2.3.3  Gas chromatography-mass spectrometry analysis of cholesterol and 
cholesterol oxidation products after kainate injections  
 An additional 14 rats were used for this portion of the study, of which 7 were 
injected with kainate and the remainder were saline-injected controls. They were 
sacrificed at 1 and 3 days after injection (3 kainate and 3 saline injected rats at 1 day, 
and 4 kainate and 4 saline injected rats at 3 days after injection). Rats were 
anesthetized by chloral hydrate injection, decapitated, and the brains removed. The 
right hippocampus (side of the intracerebroventricular injection) was rapidly 
dissected out and stored at  
-70oC  until assay. 
 All reagents for GC/MS analysis were of analytical grade obtained from 
Fisher. Standards for cholesterol, cholesterol oxidation products and 5α-choelstane 
were obtained from Sigma. All the standards were of at least 90% purity. 5α-
choelstane was used as an internal standard to correct for minor variations in injection 
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volume, response and retention time. 5α-cholestane has a similar structure to 
cholesterol and cholesterol oxidation products but is distinct from the analytes by 
retention time. Stock solutions containing 1.0mg of cholesterol and cholesterol 
oxidation products were dissolved in methanol. 5α-choelstane was dissolved in 
hexane. The stock solutions were used to prepare standard solutions of 5 ng of 
compound/ml by dilution with methanol. Extraction of lipids was carried using 
Folch’s method with slight modifications. 
 The hippocampal specimens were homogenised with 0.5 M NaCl, containing 
10 µM of butylated hydroxytoluene (BHT) to a final volume 20 times the weight of 
the tissue sample. Butylated hydroxytoluene was added to prevent oxidation of the 
samples due to the homogenisation procedure. The homogenate (0.5 ml) was then 
transferred to a 10 ml centrifuge tube, and 4 ml of extracting solvent 
(chloroform/methanol 2:1, containing 1.0 mg/ml 5α-cholestane and 10 mg/100 ml 
BHT) added. The mixture was vortexed, shaken on a linear shaker for 15 minutes, 
and centrifuged at 2500 rpm for 5 minutes. The upper phase was siphoned away and 
the lower chloroform phase was washed with 1 ml of distilled water. The upper phase 
of this mixture was then siphoned away, and the lower chloroform phase evaporated 
to dryness under a stream of nitrogen. N, O-bis(trimethylsilyl) trifluoroacetamide 
(BSTFA, 100 µl) and dry pyridine (20 µl) were added and the mixture was heated for 
30 minutes at 60°C to derivatize  to trimethylsilyl esters. The resultant mixture (2 µl) 
was then injected into the GC/MS. To rule out the possibility of artificial cholesterol 
oxidation during the extraction procedure, 4 µg/ml of cholesterol was subjected to the 
same extraction procedure. The concentrations of cholesterol oxidation products were 
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found to be under the limit of detection. Controls for the extraction procedure were 
carried out to validate that the extraction procedures described above were able to 
extract cholesterol and oxidation products from homogenates of brain tissues. This 
was carried out by spiking 20 µl of the standard solutions in homogenates of normal 
hippocampus, and carrying out the extraction procedures as described above for the 
hippocampal specimens. 
A Hewlett-Packard model 5890 gas chromatograph with a 5973 mass 
selective detector was used for the analysis. The data system was an HPVE5/233 
computer with an HPG1034C MS Chemstation program. The mass spectrometer was 
operated in the electron impact mode at 70eVwith an ion source temperature of 
230°C, and mass/charge ratio range for selected ions in the scan mode from 50 to 550 
amu. The instrument was autotuned daily with perfluorotributylamine (PFTBA). The 
GC/MS interface temperature was 280°C. A 25 mm×0.2mm i.d. cross-linked 5%-
diphenyl 95%-dimethylsiloxane HP-5 column was used for analysis. The helium flow 
rate was 1ml/min at a linear velocity of 35cm/sec. The operating temperature of the 
column varied with the analytes. The injection temperature varied from 180 to 265°C, 
and the injection was splitless. The oven temperature was 300°C, the column 
temperatures was 100°C for the first minute, followed by a 10°C/minramp to 300°C 
and hold for 12 minutes. Run time was 33 minutes with cholesterol trimethysilyl 
esters (TMS) eluting at 24 minutes, 7β-hydroxycholesterol TMS eluting at 25 minutes, 
and finally, 7-ketocholesterol TMS eluting at 28 minutes. Equilibration time was 0.50 
minutes with a 0.75 minute purge off time. The transfer line temperature was 285°C. 
The solvent delay was 0.3 minutes, and the electron multiplier was set at autotune 
 36
voltage. The MS was run under the selected-ion monitoring mode. The amount of 
cholesterol or cholesterol oxidation products detected was divided by the amount of 
internal standard detected and the weight of the starting material to enable 
comparison across samples. Statistical analysis was carried out using the Student's t-
test. 
 
2.3.3a Development of the method 
 
The present interest in measuring cholesterol oxidation products in food or 
biological fluids stems mainly from new evidence indicating that cholesterol 
oxidation products may have several adverse biological effects. The resulting interest 
is creating a huge demand for efficient analytical methods. There has been extensive 
development and abundant literature on the analytical methods suitable for 
cholesterol oxidation products quantification especially in food products. However, 
little information has been published concerning the quantification of cholesterol 
oxidation products in brain tissues. 
  We compared two of the most frequently used extraction methods for 
cholesterol oxidation products to identify the best (Folch’s and Eder’s methods). An 
alternative to the traditional Folch’s method was described by Eder et al., (1993), in 
this method the tissue samples are homogenized with a mixture of hexane/2-propanol 
for 1 minute and the resultant suspension is filtered and the filtrate rinsed with the 
same solvent mixture. The whole liquid phase is evaporated and the dried extract is 
dissolved in methanol. 
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We also compared three analytical methods used for the quantification in food 
products or biological samples. The methods were high performance liquid 
chromatography with an ultraviolet detector, gas chromatography with a flame 
ionization detector and gas chromatography – mass spectrometry.  
High performance liquid chromatography is one of the more widely used 
methods for the identification and quantification of cholesterol oxidation products. 
We used a high performance liquid chromatography method for the analysis of 
cholesterol oxidation products using a reverse-phase column since it was reported to 
result in higher reproducibility in milk products (Rose-Sallin et al., 1993). We were 
unable to detect any cholesterol oxidation products in tissue samples spiked with 
4µg/ml using the HPLC method regardless of the extraction method used. We 
expected this result because high performance liquid chromatography is widely 
accepted to be less sensitive than gas chromatography – mass spectrometry. Moreover 
we used a solvent system that was different to what was described in other published 
papers (Anasari et al., 1979; Kou et al., 1985; Teng et al., 1991). 
The combination of gas chromatography and the flame ionization detector was 
reported to provide a powerful tool to precisely quantify cholesterol oxidation 
products (Tai et al., 1999). However we were unable to detect any cholesterol 
oxidation products in tissue samples spiked with 4 µg/ml using the GC(FID) method 
regardless of the extraction method used. 
Gas chromatography – mass spectrometry quantification is widely accepted as 
the most selective and sensitive means to identify and quantify cholesterol oxidation 
products (Rose-Sallin et al., 1995). We were able to identify the cholesterol oxidation 
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products using this method in tissue samples extracted using Folch’s method. This 
was done by comparing the mass spectrum with the established chemical library 
which enabled us identify cholesterol oxidation products with high accuracy.  For 
cholesterol and cholesterol oxidation products analysis, the conversion of these 
compounds to trimethysilyl (TMS) ester derivatives is a frequently applied step 
(Iuliano et al., 2003). Derivatizing the samples aids the chromatography such that 
sharper, more easily defined peaks are present for better detection. The ions of the 
derivatized samples are more easily discerned because they are in the higher mass 
range than those of the underivatized samples. We added 5α-cholestane as an internal 
standard because it can correct for minor variations in injection volume, response and 
retention time. Moreover, the compound is chemically similar to the cholesterol 
oxidation products, not present in brain tissue, but distinct from the cholesterol 
oxidation products by retention time.  
Some practical considerations which we did not adhere to resulted in having 
to repeat the entire experiment. One of those was the addition of an antioxidant such 
as butylated hydroxytoluene (BHT), which prevents oxidation at the various stages of 
the extraction procedure.   
 
2.3.4  Effects of cholesterol and cholesterol oxidation products on hippocampal 
slice cultures 
 At 7 days in culture, hippocampal slices were treated with cholesterol, 25-
hydroxycholesterol, 7-ketocholesterol, cholesterol 5α, 6α-epoxide and cholesterol  5β, 
6β-epoxide (1:10 dilution from a 10 mM stock solution in 5% ethanol). A1:10 
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dilution of 5% ethanol alone was added to some of the cultured slices, as a control. To 
elucidate the effect of glutathione on toxicity of cholesterol oxidation products, 
separate plates of  cultured slices were used, in which 0.33 mM of reduced 
glutathione was added 30 minutes before addition of cholesterol oxidation products. 
This concentration of glutathione has been shown to be effective in protecting 
neurons against β-amyloid induced toxicity in vitro (Sandhya et al., 1998). 
The slices were fixed in 4% PF in 0.1 M phosphate buffer (pH 7.4) one day 
after treatment. The polytetrafluoroethylene membranes were cut from the culture 
plate inserts, and processed with the attached slices for immunocytochemistry to 
GluR1 using the same method described for brain sections. On completion of 
immunostaining, the slices were detached from the membranes, and mounted on 
gelatinized slides. Images of the slices were then captured at x2.5 magnification, 
using a Zeiss Axiophot microscope and analysed using Image Pro Plus software 
(Media Cybernatics, Silver Spring, MD). A curved line was traced along the row of 
hippocampal pyramidal neuronal cell bodies from CA1to CA4, followed by a second 
trace, along the pyramidal neurons that showed GluR1 staining. The length of the 
second trace was expressed as a percentage of the first trace as an indication of 
“uninjured” pyramidal neurons in the hippocampus. All tracings were done “blind” 
on coded slides. Six to 12 slices in each treatment category were analysed. Possible 
statistical differences between the treatment groups were analysed, using the 






























3.1 Immunocytochemical labeling of cholesterol in hippocampal sections 
after kainate injection. 
 
3.1.1 Light microscopy 
3.1.1a Saline- injected rats 
 The hippocampus of saline-injected rats showed dense immunoreactivity for 
the AMPA receptor subunit GluR1 (Figure 3A) but only very light immunoreactivity 
for cholesterol (Figure3B). 
 
3.1.2b One and three days after kainate injection 
 A decrease in GluR1 staining was observed in portions of CA fields at one 
day post-injection, indicating areas of neuronal injury (Figure 3). The decrease in 
GluR1 staining was accompanied by an increase in cholesterol immunostaining in the 
neuropil (Figure 3D) and occasional cell bodies of neurons, in adjacent sections. A 
further increase in cholesterol staining was observed in the degenerating CA field at 3 
days post-kainate injection (Figure 3E). Staining was observed in cell bodies of 
degenerating neurons and the neuropil in the affected CA fields.  
 
3.1.3c One and two weeks after kainate injection 
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 Areas affected by the kainate injection showed loss of neurons, and a dense 
glial reaction in Nissl sections. The degenerating neurons at the edge of the glial scar 
were densely stained for cholesterol, whereas glial cells in the center of the lesions 
were lightly stained (Figure3F). 
 
Figure 3. Light micrographs of saline and kainate lesioned hippocampus. A, B: 
sections of field CA1 from the saline treated hippocampus, showing dense staining of 
the AMPA receptor GluR1 in the cell bodies of pyramidal neurons and the neuropil 
(A, asterisk), but light staining with the antibody to cholesterol (B, asterisk). C, D: 
sections of field CA1 from a rat which has been injected with kainate 1 day earlier, 
showing decrease in staining in the affected CA field (C, asterisk), but increase in 
staining to cholesterol (D, asterisk). E: higher magnification of field CA3 of a rat 
which has been injected with kainate 3 days earlier, showing dense cholesterol 
staining in degenerating pyramidal neurons (arrows). F: section through the center of 
the glial scar of a lesioned CA1 from a rat that has been injected with kainate one 
week earlier. In contrast to the dense staining of cholesterol in neurons, only light 
staining for cholesterol is observed in glial cells (arrows). Scale: A-D = 150 µm; E, F 






3.1.2  Electron microscopy 
 
 In contrast to the normal untreated and saline-injected rat hippocampus, which 
showed very little staining, dense staining for cholesterol was observed in the 
neuropil, in the one day post-kainate-injected hippocampus. Labeling was observed 
on the cell membranes of processes in the neuropil and the extracellular space, but 
was absent from endothelial cells of blood vessels (Figure 4A). 
The cell bodies of neurons were labeled, in addition to processes in the 
neuropil, at 3 days post-kainate injection. The nucleus of the neurons was still intact, 
although large numbers of vacuoles were observed in the cytoplasm (Figure 4B).  
At one week post-kainate injection and beyond, labeled degenerating neurons 
were observed at the edge of the lesioned CA field. The cell and nuclear outlines were 
indistinct and large numbers of vacuoles were observed in the cytoplasm (Figure 4C).  
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Figure 4. Electron micrographs of kainate lesioned hippocampus stained with an 
antibody to cholesterol. A: section of field CA1, from a rat which has been injected 
with kainate 1 day earlier, showing dense staining of the intercellular space and cell 
membranes in the neuropil (arrows), but no staining of the endothelial cells lining a 
capillary. BL: basal lamina, E: endothelial cells, L: lumen of the capillary. B: 
micrograph of a partially degenerating neuron in a lesioned CA field, in a 3-day post-
kainate injected rat. The nucleus (N) is intact, although large numbers of vacuoles (V) 
are observed in the cytoplasm. Arrows indicate immunoreaction product. C: 
micrograph of a degenerating neuron at the edge of a lesioned CA field, in a one 
week post-kainate injected rat. The cell and nuclear outlines are indistinct and large 
numbers of vacuoles are observed in the cytoplasm. Arrows indicate immunoreaction 
product. Scale: A=1.0 µm; B= 1.5 µm; C= 2.5 µm. 
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3.2 Filipin histochemical labeling of cholesterol in hippocampal sections, 
slices, and neuronal cultures after kainate treatment 
 
3.2.1  Hippocampal sections 
A light, punctate staining was observed in cytoplasmic organelles, in the 
saline injected rats (Figure 5A). In contrast, a marked increase in staining was 
observed in the CA field, at one and 3 days post-kainate injection. The cell bodies and 
dendrites of degenerating neurons were densely stained, but only few labeled glial 
cells were observed (Figure 5B). 
At 1 and 2 weeks after kainate injection, degenerating neurons at the edge of 
the glial scar were densely stained for filipin, whereas glial cells in the center of the 
lesions were unstained or lightly stained. 
 
3.2.2 Hippocampal slice cultures 
 Untreated slices showed very little filipin staining (Figure 5C). In contrast, an 
increase in filipin staining was observed after kainate treatment. The increase was 
observed in degenerating neurons in the CA fields (Figure 5D). 
 
3.2.3 Hippocampal neuronal cultures 
 Untreated cultured hippocampal neurons showed very little filipin staining 
(Figure 5E). In contrast, an increase in filipin staining was observed in cultured 
hippocampal neurons one day after kainate treatment (Figure 5F). Staining was 
observed in the cell bodies, axons and dendrites of these neurons. Treatment of 
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hippocampal neurons with lovastatin, an inhibitor of cholesterol synthesis, resulted in 
fewer filipin-labeled cells: the percentage of filipin labeled neurons to the total 
number of neurons identified at brightfield was 64±8 % for neurons that were treated 
with kainate only (n=570), compared to 46±5 % for neurons that were treated with 
lovastatin plus kainate (n=791). The difference was significant by t-test (p<0.05). 
 
Figure 5. Light micrographs of hippocampal sections, slices and neurons, stained 
with a histochemical method for cholesterol (filipin stain). A: section through field 
CA3 of a saline injected rat, showing little staining to cholesterol. B: section through 
field CA3 of a rat which has been injected with kainate 1 day earlier, showing intense 
filipin staining in the affected hippocampal neurons (arrows). C: field CA1 of an 
untreated hippocampal slice, showing very little or no staining in hippocampal 
neurons (arrows). D: field CA1 of a slice that has been treated with kainate, showing 
dense staining of degenerating pyramidal neurons. E: untreated hippocampal neuron 
(arrow), showing very little or no staining to filipin. F: hippocampal neurons that 
have been treated with kainate 1 day previously, showing increases in staining to 






3.3 Gas chromatographic-mass spectrometric (GC-MS) analysis of 
cholesterol and cholesterol oxidation products in hippocampal homogenates 
after kainate treatment 
 
3.3.1 Saline-injected rats 
 Cholesterol and all cholesterol oxidation products could be detected in 
samples of normal brain that had been spiked with minute quantities of these 
compounds (Figure 6). Ions at mass charge (m/z) ratios 458 (cholesterol TMS), m/z 
131 (25-hydroxycholesterol TMS), m/z 472 (7-ketocholesterol TMS), m/z 456 (7β-
hydroxycholesterol TMS), m/z 474(cholesterol 5α,6α-epoxideTMS and cholesterol 
5β,6β-epoxide TMS) and ions at m/z 372 (5α-cholestane TMS) were used to quantify 
cholesterol and cholesterol oxidation products as previously described (Tsuzuki et al., 
2000). A baseline level of cholesterol was detected in homogenates from the 
hippocampi of saline-injected (Table 1) and one-day post-saline injected rats (Table 
1). In addition, a baseline level of the cholesterol oxidation product 7β-
hydroxycholesterol and 7-ketocholesterol (mean=3 and 13 µg/g tissue respectively) 
was also detected in these extracts (Figure 6). These cholesterol oxidation products 
were detected, despite the addition of BHT to the aqueous homogenization mixture 
and the organic extracting solvents to protect against oxidative damage, and could 
represent basal levels of these products that are present in normal brain tissues. 
Cholesterol added and carried through the extraction procedure did not result in 







Figure 6. Detection of cholesterol and COPs in brain tissues spiked with these 
compounds. Ions at mass charge (m/z) ratios 458 (cholesterol TMS), m/z 131 (25-
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hydroxycholesterol TMS), m/z 472 (7-ketocholesterol TMS), m/z 456 (7β- 
hydroxycholesterol TMS), m/z 474(cholesterol 5α, 6α-epoxide TMS and cholesterol 
5β, 6β-epoxide TMS) were used to quantify cholesterol and COPs. 
 
3.3.2 One day after kainate injection 
 A trend to an increase (7%), in cholesterol was observed in the kainate- 
injected brains compared to the saline-injected brains at one day post-kainate 
injections, although the difference was not statistically significant. 25-
hydroxycholesterol, cholesterol 5α,6α-epoxide and cholesterol 5β,6β-epoxide were 
found to be under the limit of detection in both the saline-injected and kainate- 
injected brains, even though they were detected in homogenates of normal 
hippocampi that had been spiked with minute amounts (2 and 4 µg/ml) of these 
compounds (Figure 6). 
 
3.3.3 Three days after kainate injection 
 An increase of 70% and 79%, and 32% in cholesterol, 7β-hydroxycholesterol  
and 7-ketocholesterol respectively were observed in the kainate-injected brains 
compared to the saline-injected brains. These differences were found to be 
statistically significant. 25-hydroxycholesterol, cholesterol 5α,6α-epoxide and 
cholesterol 5β,6β-epoxide were found to be below the limit of detection in both the 
saline and kainate-injected brains, even though they were detected in homogenates of 
untreated hippocampi which had been spiked with minute amounts (2 and 4 µg/ml) of 





 n Days post 
kainate 
injections 
Mass Ion (Kainate-saline/saline) 
x 100 (%) 
P 
Cholesterol 3 1 458 7±11 0.59 
7-ketocholesterol 3 1 472 0±16 1.00 
7β-hydroxycholesterol 3 1 456 -2±8 0.84 
Cholesterol 5α, 6α-epoxide 3 1 474 Not detected  
Cholesterol 5β, 6β-epoxide 3 1 474 Not detected  
25-hydroxycholesterol 3 1 131 Not detected  
Cholesterol 4 3 458 70±16 0.005 
7-ketocholesterol 4 3 472 32±9 0.022 
7β-hydroxycholesterol 4 3 456 79±28 0.030 
Cholesterol 5α, 6α-epoxide 4 3 474 Not detected  
Cholesterol 5β, 6β-epoxide 4 3 474 Not detected  
25-hydroxycholesterol 4 3 131 Not detected  
 
Table 1. Increases in cholesterol and cholesterol oxidation products after kainate 
treatment. Kainate-saline/saline ×100% indicate the percentage increase in kainate 

















3.4 Effects of cholesterol and cholesterol oxidation products on hippocampal 
slice cultures 
 
As described previously, dense GluR1 staining was observed in “normal” 
untreated slices, or slices treated with 5% ethanol alone (Figure 7A; Table 2). 
Incubation of slices with cholesterol resulted in no significant decrease of GluR1, 
indicating that cholesterol per se was not harmful to neurons (Figure 7B; Table 2). In 
contrast, a decrease in GluR1 staining was observed in the CA fields, in rats 
incubated with cholesterol oxidation products (Figure 7C, D; Table 2). The greatest 
decrease was observed with cholesterol 5β,6β-epoxide followed by 7-ketocholesterol 
and cholesterol 5α, 6α-epoxide (Table 2).  
Incubation of slices with reduced glutathione prior to addition of cholesterol 
oxidation products was effective in reducing the damage produced by these products. 
The addition of glutathione prior to addition of 7-ketocholesterol and cholesterol 5, 6, 
epoxides significantly prevented the decreases in GluR1immunoreactivity in the CA 










 Treatment X±SEM P(<0.001) 
A Untreated 97.5±3.8 vs F,H,J 
B 5% ethanol 94.5±4.3 vs F,H,J 
C Cholesterol 94.9±3.2 vs F,H,J 
D 25-Hydroxycholesterol 90.7±5.1 vs F,H,J 
E Glutathione + 25-hydroxycholesterol 92.3±4.8 vs F,H,J 
F 7-Ketocholesterol 44.1±10.4 vs G,I,K 
G Glutathione + 7-ketocholesterol 86.1±12.9 vs H,J 
H Cholesterol 5α, 6α-epoxide 55.4±14.6 vs I,J,K 
I Glutathione + Cholesterol 5α, 6α-epoxide 94.1±3.8 vs J 
J Cholesterol 5β, 6β-epoxide 38.0±21.4 vs K 
K Glutathione + Cholesterol 5β, 6β-epoxide 85.7±13.4 As above 
 
Table 2. Toxicity of COPs and modulation of toxicity by reduced glutathione. 
The slices were untreated, treated with 5% ethanol, cholesterol, or COPs 25-
hydroxycholesterol, 7-ketocholesterol, cholesterol 5α, 6α-epoxide, and cholesterol 5β, 
6β-epoxide. Normal untreated slices, or slices treated with 5% alcohol (a solvent for 
cholesterol and COPs), or cholesterol showed almost complete staining of the 
pyramidal cell layer. In contrast, incubation of slices with COPs resulted in 
significant decreases in GluR1 staining in the CA fields. Incubation of slices with 
reduced glutathione prior to addition of COPs was effective in reducing the damage 
produced by COPs. The values represent means ± SEM (n = 10 to 12 in each set) of 
the percentage of a line drawn along the entire length of the CA field that shows 
GluR1 positive pyramidal neurons was calculated, and converted to a percentage. 
Analyzed by one-way ANOVA with Bonferroni’s multiple comparison post-hoc test. 
Significant differences (P<0.001): A vs F,H,J; B vs F,H,J; C vs F, H,J; D vs F,H, J; E 




Figure 7. Field CA1 of hippocampal slices after treatment. A-D: field CA1 of 
hippocampal slices that have been treated with ethanol, cholesterol or COPs, 7-
ketocholesterol and cholesterol 5α, 6α-epoxide, and immunolabelled with antibody to 
a neuronal marker, GluR1. Dense staining for GluR1 is observed in the cell bodies 
and dendrites of pyramidal neurons in the slices treated with ethanol (A, arrow) or 
cholesterol (B, arrow). This staining is absent in slices treated with COPs 7-
ketocholesterol (C, arrow) or cholesterol 5_, 6_-epoxide (D, arrow). E, F: field CA1 
of hippocampal slices which have been treated with glutathione, followed by 
cholesterol oxidation product 7-ketocholesterol (E) or cholesterol 5α, 6α-epoxide (F), 
and immunolabelled for GluR1. Dense staining for GluR1 is observed in the cell 
bodies and dendrites of pyramidal neurons in both cases (arrows in E and F) 
indicating a protective effect of reduced glutathione on loss of the neuronal marker. 





























 It was found that kainate-induced neuronal injury resulted in an increase in 
cholesterol as shown by 3 different methods (immunostaining, filipin histochemistry 
and GC/MS). The mechanisms by which kainate injections result in the increase in 
cholesterol in the hippocampus remain unclear. This may be due to the fact that 
cholesterol may be synthesized in response to neuronal injury induced by kainate or 
the degradation of cell membranes. The increase in cholesterol is accompanied by 
accumulation of 7-ketocholesterol 3 days post-kainate treatment. The results thus 
suggest a free radical attack on the increased cholesterol. The actual mechanisms of 
possible elevations of cholesterol oxidation products after kainate-induced excitotoxic 
brain injury are far more complex and are likely to remain unresolved until more 
specific studies are conducted. 
The addition of cholesterol oxidation products to hippocampus slices resulted 
in neuronal injury was attenuated by treatment with the antioxidant glutathione, 
showing that it occurred through oxidative mechanisms. The results of this study 
suggest that cholesterol oxidation products may be a factor in the continuing and 
aggravating neurotoxicity, although they are not responsible for the initial stages of 
kainate-induced neuronal injury.  
A decrease in GluR1 is generally accepted as a sensitive indicator of areas of 
neuronal injury (Ong et al., 2000a, 2000b).  An increase in cholesterol staining was 
observed in areas of the hippocampus that showed decreased GluR1 after kainate 
treatment. The staining was observed in the cell bodies of degenerating neurons. In 
contrast, glial cells were not labeled or only lightly labeled, indicating that they were 
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not the main cell types that were responsible for the increased cholesterol after 
kainate lesions. Staining was also absent from the endothelial cells in the lesioned CA 
fields, indicating that increased transport of cholesterol across the blood brain barrier 
in these regions was unlikely. 
An increase in filipin staining was observed in the degenerating CA fields in 
hippocampal slice cultures after kainate treatment. The increase in filipin staining in 
slices shows that the increase in cholesterol after kainate treatment is independent of 
cholesterol that could have been contributed by peripheral organs. The effect of 
kainate on filipin staining was then studied using dissociated hippocampal neural 
cultures. Additions of kainate to “pure” neuronal cultures that have been treated with 
cytosine arabinoside to eliminate glial cells resulted in a marked increase in filipin 
staining in neurons after kainate treatment and indicated that increase in filipin 
staining did not require glial cells. These observations are consistent with the results 
of cholesterol immunocytochemistry and filipin histochemistry which showed no or 
light labeling of cholesterol in glial cells. 
We added lovastatin to elucidate whether increased synthesis of cholesterol in 
neurons might contribute to the increased filipin staining in neurons. The addition of 
lovastatin, an inhibitor of a key enzyme in cholesterol synthesis, HMG-CoA, resulted 
in significantly smaller proportion of neurons that were labeled with filipin, indicating 
that free cholesterol in the neurons was inhibited by the addition of the drug and that 
neurons are likely to increase their synthesis of cholesterol after kainate treatment. 
The amount of increase in cholesterol in the hippocampus after kainate 
treatment was quantified using gas chromatography/mass spectrometry. It was found 
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that after kainate treatment there was an increase in the amount of cholesterol in the 
hippocampus although the increase was not significant for one-day post kainate 
injected rats. Researchers have reported that very little cholesterol is thought to cross 
from the bloodstream to the brain parenchyma (Dietschy and Turley, 2001). This 
leads to speculation that there must be some other mechanism involved other than 
redistribution due to membrane breakdown. In addition to the increase in cholesterol, 
an increase in cholesterol oxidation products, 7β-hydroxycholesterol and 7-
ketocholesterol was also observed. This observation suggests a free-radical-mediated 
attack on the increase cholesterol. 
 Some of the cholesterol oxidation products, including 7-ketochoesterol and 
cholesterol epoxides were found to cause neuronal injury when applied to hippcampal 
slice cultures. In the present study only 7β-hydroxycholesterol and 7-ketochoelsterol 
but not the other COPs were detected by GC/MS. One possible explanation might be 
that the oxidation of the C7 position of the cholesterol ring may be more important 
that that of other carbon positions in the generation of cholesterol oxidation products 
after kainate injury. Another explanation is that 25- hydroxycholesterol, cholesterol 
5α, 6α-epoxide and cholesterol 5β, 6β-epoxide are under the limit of detection in both 
saline and kainate injected brains which suggests that they may be present at very low 
concentrations or further steps to enrich the compounds are needed. The use of C18 
cartridges or Sep-Pak silica cartridges have been shown to improve the recovery of 
the compounds for identification and quantification of COPs (Iuliano et al., 2003).  
  One of the drawbacks of the GC/MS method is the need for a derivatization 
step for GC separation, which extends analysis time and may affect quantification 
 58
accuracy. HPLC may seem to be more suitable as analysis is usually carried out under 
ambient temperatures and the likelihood of formation of artifacts are eliminated. 
However the resolution power of the HPLC is inferior to that of the GC/MS. Thus, 
the GC/MS is more suitable for analysis of cholesterol and COPs in the rat 
hippocampus. 
Another drawback of this method is the performance of the GC-MS tends to 
deteriorate after 15 runs. Hence, to ensure that the instrument maintains a high level 
of sensitivity, the ion source has to be cleaned after every 15 runs to remove 
contamination from the surface. Removing this contamination restores the 
electrostatic properties of the ion source.  Improving the extraction and purification 
procedures may reduce the frequency of cleaning the ion source. Contamination is the 
leading cause of problems in the gas chromatograph system. 
Finally, a significant difference was observed between slices treated with 
reduced glutathione and cholesterol oxidation products and those treated with 
cholesterol oxidation products alone. This seems to suggest that cholesterol oxidation 
products exerted their harmful effects on neurons by a free radical mechanism and 
that may be prevented by antioxidants like glutathione. 
The molecular mechanism involved in the upregulation of cholesterol 
synthesis in kainate-induced neurotoxicity remains unknown. In brain tissue 
cholesterol is an integral component of neural membranes. It is involved in 
maintaining neural membrane properties such as membrane order, phospholipids 
bilayer phase transition, permeability and fluidity (Yaegle, 1991). Cholesterol is 
involved in APP processing and acts as antioxidant in beta amyloid neurotoxicity in 
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cell culture models (Hartmann et al., 1994, Zhou and Richardson, 1996). The present 
results are consistent with the suggestion that in response to kainate-induced 
oxidative stress, those pyramidal neurons that escape cell death upregulate their 
cholesterol synthesizing machinery not only for maintaining their own membrane 
integrity but also for synthesizing new membranes (Vance et al., 1994). Neurons have 
vast cellular membranes and plastic membrane synthesis involving axonal growth and 
synaptogenesis requires constant supply of cholesterol and other phospholipids and 
glycosphingolipids molecules (Farooqui et al., 2000). In biomembranes the dynamic 
clustering of cholesterol produces specialized microdomains or raft which play 
crucial role in cellular functions such as signal transduction, adhesion and sorting and 
trafficking of membrane components (Simon and Ikonen, 1997). The excess 
cholesterol in membrane if injured degenerating neurons is metabolized to 7-
ketocholesterol, 24 hydroxycholesterol and 25 hydroxycholesterol. In vitro studies 
have indicated that the treatment of neural cell cultures with 7-ketocholesterol, 24-
hydroxycholesterol and 25-hydroxycholesterol results in stimulation of caspase-3 and 
nitric oxide synthase activities (Chang et al., 1998; Lizard et al., 2000; Kolsch et al., 
2001). Evidence supports the suggestion that the interplay between abnormalities in 
cholesterol and phospholipids metabolism is closely associated with neural membrane 
integrity and neurodegenerative processes (Farooqui et al., 2001). Further studies are 
necessary to elucidate possible elevation of cholesterol and cholesterol oxidation 
products in neurodegenerative diseases and the precise mechanism of neuronal 
damage resulting from cholesterol oxidation products. 
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The present study could be extrapolated to include animals sacrificed over a 
longer time frame and quantification of other COPs. Finally, the precise mechanism(s) 
of neuronal damage resulting from COPs deserves further investigation. The evidence 
that cholesterol and cholesterol oxidation products play a role in neuronal damage 
continues to increase. The major challenges for the future will be to determine the 
roles played by cholesterol and cholesterol oxidation products at different time points 
of neurodegeneration and to determine a possible role of phospholipase A2 in 
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